Figures computed from official regulatory filings — .
Analysttarget 5 USD (+542%) · consensus 5/5 · 1 buy · 0 hold · 0 sell
Ownershipinsiders 3.58% · institutions 43.82% · short 0.0% of float
In USD · as of Oct 5, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for ELUTIA INC. only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
Elutia Inc., a commercial-stage company, focuses on developing drug-eluting biomatrix products for use in surgical reconstruction and related applications. The company operates in two segments, Women's Health and Cardiovascular. Its lead development programs include NXT-41 and NXT-41x, which are designed as biologic scaffolds combined with local antibiotic delivery. The company provides SimpliDerm, a human acellular dermal matrix used in soft tissue reconstruction. It also offers ProxiCor for cardiac tissue repair for use as an intracardiac patch for repairs, such as atrial and ventricular septal defects and suture-line buttressing, and pledgets, as well as for pericardial closure to reconstruct the pericardium after heart surgery. In addition, the company provides Tyke, a thinner pliable matrix for the repair of pericardial structures for neonates and infants; as an epicardial for damaged or repaired cardiac structures; and as a patch material for cardiac defects, as well as VasCure, a patch material to repair or reconstruct the peripheral vasculature. The company sells its products directly to hospitals and other healthcare facilities through independent sales agents. The company was formerly known as Aziyo Biologics, Inc. and changed its name to Elutia Inc. in September 2023. Elutia Inc. was incorporated in 2015 and is headquartered in Gaithersburg, Maryland.
Market information source · Oct 5, 2026
Periods recorded in the consulted sources. These do not certify the legal dates of name changes.
SEC company identity · Oct 5, 2026
Open-market timeline · full history
45 buys2 sells— close pricebar = usd volume, √ scaleclick a period to filter the table
| Insider | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
| Mills C Randaltrack record | Other | $7.8K | SEC |
| Ferguson Matthewtrack record | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Williams Michelle LeRoux | Exercise | n/a (No price was disclosed in the filing) | SEC |
| Williams Michelle LeRoux | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Mills C Randaltrack record | Exercise | n/a (No price was disclosed in the filing) | SEC |
| Mills C Randaltrack record | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Williams Michelle LeRoux | Other | $3.4K | SEC |
| Ferguson Matthewtrack record | Exercise | n/a (No price was disclosed in the filing) | SEC |
| Ferguson Matthewtrack record | Other | $3.6K | SEC |
| Mills C Randaltrack record | Other | $8.5K | SEC |
| Mills C Randaltrack record | Exercise | n/a (No price was disclosed in the filing) | SEC |
| Mills C Randaltrack record | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Colpman David | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| RAKIN KEVINtrack record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| NEELS GUIDO Jtrack record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Makes Brigidtrack record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Williams Michelle LeRoux | Exercise | n/a (No price was disclosed in the filing) | SEC |
| Mills C Randaltrack record | Other | $10.1K | SEC |
| Ferguson Matthewtrack record | Exercise | n/a (No price was disclosed in the filing) | SEC |
| Ferguson Matthewtrack record | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Williams Michelle LeRoux | Other | $4.4K | SEC |
| Mills C Randaltrack record | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Mills C Randaltrack record | Exercise | n/a (No price was disclosed in the filing) | SEC |
| Ferguson Matthewtrack record | Other | $4.7K | SEC |
| Williams Michelle LeRoux | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |